Indications and use of, and incidence of major bleeding with, antithrombotic agents in myelodysplastic syndrome
Marc Sorigué(Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol), Blanca Xicoy(Hospital Universitari Germans Trias i Pujol), Laia Lopez‐Viaplana(Hospital de Mataró), Edurne Sarrate(Universitat Autònoma de Barcelona), Cristian Morales‐Indiano(Hospital Universitari Germans Trias i Pujol), Javier Nieto(Johns Hopkins University), José‐Tomás Navarro(Universitat Autònoma de Barcelona), Mireia Santos-Gómez(Universitat Autònoma de Barcelona), María José Jimenez(Institut Català d'Oncologia), Josep‐María Ribera(Universitat Autònoma de Barcelona), Elisa Orna(Universitat Autònoma de Barcelona)
Cited by 3
Related Papers
Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study
|The Lancet Oncology|2014|1.3k
Acute lymphoblastic leukaemia in adult patients: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2016|457
Underdiagnosis of Sleep Apnea Syndrome in U.S. Communities
|Sleep And Breathing|2002|434